On Jan. 20, 2025, the White House announced the United States will exit the World Health Organization (WHO)….
On Jan. 20, 2025, the World Health Organization (WHO) announced that Tanzania has confirmed an outbreak of Marburg…
On Jan. 15, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) released an Interim…
On Jan. 13, 2025, the World Health Organization (WHO) informed its Member States and IHR State Parties of…
On Dec. 20, 2024, the World Health Organization (WHO) announced that the outbreak of Marburg Virus Disease was…
On Dec. 9, 2024, the Africa Centers for Disease Control (CDC) announced that it is working closely with…
On Oct. 14, 2024, RedHill Biopharma announced that the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA)…
On Oct. 11, 2024, the World Health Organization (WHO) reported that a total of 58 cases of Marburg…
On Aug. 21, 2024, French and Democratic Republic of the Congo (DRC) researchers announced that a real-world study…
On Aug. 1, 2024, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO) called…
On Jul. 15, 2024, the Sabin Vaccine Institute launched a Phase 2 clinical trial for its vaccine against…
![European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older](https://www.lifesciencehistory.com/wp-content/uploads/2022/08/european_commission_logo-768x768.jpg){kind=logo}
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
On Aug. 3, 2023, Merck announced that the U.S. Food and Drug Administration (FDA) had approved an expanded…
On Jul. 31, 2023, Emergent BioSolutions announced that it was awarded a 10-year contract by the Biomedical Advanced…
On Jul. 28, 2023, the U.S. Food and Drug Administration (FDA) approved Merck’s Ervebo, a vaccine for the…
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
On Jan. 11, 2023, Uganda declared the end of the Ebola disease outbreak caused by Sudan ebolavirus, less…
On Dec. 15, 2022, the University of Oxford Oxfordï¾’s Ebola vaccine candidate has been shipped to Uganda, just…
On Dec. 9, 2022, the World Health Organization (WHO) announced that the first doses of one of the…
On Sept. 20, 2022, The health authorities in Uganda declared an outbreak of Ebola after a case of…
On Sept. 17, 2022, the Democratic Republic of the Congo declared the end of an Ebola outbreak that…
On Apr. 28, 2022, the Ministry of Health of the Democratic Republic of the Congo declared an outbreak…
On Dec. 16, 2021, the Ebola outbreak that erupted in the Democratic Republic of the Congo’s North Kivu…
On Aug. 14, 2021, the Ministry of Health of Cote d’Ivoire confirmed the country’s first case of Ebola…
On Aug. 9, 2021, health authorities in Guinea confirmed a case of Marburg virus disease in the southern…
On Jun. 19, 2021, the Ebola outbreak that emerged in Guinea in mid-February was declared over. It was…
On May 3, 2021, the World Health Organization (WHO) announced the end of the 12th outbreak of Ebola…
On Feb. 14, 2021, the WHO announced that Health authorities in Guinea had declared an outbreak of Ebola…
On Dec. 21, 2020, the NIH announced a study published in Proceedings of the National Academy of Sciences…
On Oct. 14, 2020, Regeneron announced that the FDA had approved Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for the…